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Sir,
We thank Lipsitch and Shaman1 for their comments on our article2
on the antibiotic footprint, which we proposed as a simple means
of communication to aid public understanding. The total amount
of consumption of different antibiotics could predominantly affect
the development and spread of antibiotic resistance in the sector
VC The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.
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where the antibiotics are used. However, there are spillovers of an-
tibiotic resistance into other sectors,3 which is why we believe the
concept of a total footprint is useful. If we reduce antibiotic use in
the agriculture sector it may result in less resistance in bacteria col-
onizing and/or infecting people.3 We agree that the antibiotic foot-
print could be improved by better taking account of the impact of
antibiotic consumption in different sectors and for different types
of antibiotics, and would wish to see research in this area in the fu-
ture.2 On the issue of how antibiotic volumes should best be
expressed, as data and epidemiological and modelling studies be-
come increasingly available, researchers may be able to convert
tonnes of different types of antibiotics used in different sectors to
penicillin equivalent (just for a notion and an example). The com-
plex models for converting each specific drug for each specific sec-
tor could be widely debated and later decided upon among
researchers and stakeholders in order to support communication
with the public.
We proposed that antimicrobial consumption should be re-
duced to a minimum, not to zero, and we agree that access to anti-
biotics for those who have to use them must not be
compromised.2 The antibiotic footprint could also be used, how-
ever, to promote this concept and stimulate people to ask whether
underuse or poor access to antibiotics occurs in some areas. For ex-
ample, on average in 2015, a person living in the Netherlands,
where misuse of antibiotics in humans and problems of access to
antibiotics among those who have to use them are very low, di-
rectly consumed about 3.3 g of antibiotic.2,4 A person living in
Burundi, Azerbaijan or the Philippines directly consumed 1.6, 2.8
or 3.0 g of antibiotics, respectively, in 2015,2,4 and underuse or
poor access of antibiotics may be a major problem requiring urgent
action. Overuse of antibiotics might also occur in some areas, or of-
ficial data on antibiotic consumption might be incomplete. A tool
such as the antibiotic footprint could be used to communicate with
the public and stakeholders to promote studies and actions.
We are aware of the potential concerns that clinicians, veteri-
narians or farmers could switch antibiotic type to minimize the to-
tal kilograms/tonnes used; however, many actions could be taken
to monitor and discourage inappropriate changes. First, data on
each antibiotic’s usage in each sector from each country should be
made openly available. Additional advanced metrics (such as DDD,
mg/population correction unit, mg/kg, daily dose metrics and
course dose metrics) can then be used by researchers and stake-
holders to evaluate the changes in usage in greater detail. Second,
actions from governments and stakeholders are always needed.
For example, the USA has reported a 43% decrease in antibiotic
consumption in animals from 9702 tonnes in 2015 to 5559 tonnes
in 2017.5,6 There was also a decrease in most of the medically im-
portant antibiotics as the FDA’s new rules require veterinary over-
sight of usage, and these drugs can no longer be purchased over
the counter.5,6 This could be used to inform stakeholders in many
low- and middle-income countries that reducing antibiotic con-
sumption in animals without an increase in animal health or
food safety problems is possible.6 Nonetheless, a 24% increase
in fluoroquinolone use from 18.5 tonnes in 2016 to 22.9 tonnes
Figure 1. Antibiotic consumption in humans and animals. Reproduced from https://www.gov.uk/7 under the terms of the Open Government
License v3.0. This figure appears in colour in the online version of JAC and in black and white in the print version of JAC.
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in 2017 was also observed,5 and additional actions from the
government and stakeholders are being taken to further reduce
antibiotic consumption in animals to a minimum.6 Another ex-
ample of a concept used by a government is the UK One Health
Report 2013–2017, which highlights a reduction of 19% in the
total tonnage used by humans and in animals, with animal use
contributing a 35% reduction and humans a 6% reduction
(Figure 1).7 The report also presents data showing that the pro-
portion used in humans rose to 64% from 55% during the period
covered by the report. These data assisted in the development
of goals within the UK Antimicrobial Resistance National Action
Plan 2019–2024.8
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